These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 31151073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased Occurrence of Valproic Acid-Induced Hyperammonemia in Carriers of T1405N Polymorphism in Carbamoyl Phosphate Synthetase 1 Gene.
    Janicki PK, Bezinover D, Postula M, Thompson RS, Acharya J, Acharya V, McNew C, Bowman JD, Kurkowska-Jastrzebska I, Mirowska-Guzel D.
    ISRN Neurol; 2013; 2013():261497. PubMed ID: 23997965
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
    Kwack DW, Kim DW.
    Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
    [Abstract] [Full Text] [Related]

  • 9. Perioperative exacerbation of valproic acid-associated hyperammonemia: a clinical and genetic analysis.
    Bezinover D, Postula M, Donahue K, Bentzen B, McInerney J, Janicki PK.
    Anesth Analg; 2011 Oct; 113(4):858-61. PubMed ID: 21821508
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort.
    Habhab SF, Ulvin LB, Taubøll E, Svalheim S, Olsen KB, Horn MA, Heuser K.
    Epilepsy Behav; 2020 Oct; 111():107193. PubMed ID: 32759060
    [Abstract] [Full Text] [Related]

  • 13. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions.
    Duman B, Can KC, Ağtaş-Ertan E, Erdoğan S, İlhan RS, Doğan Ö, Kumbasar H, Çamsarı UM.
    Gen Hosp Psychiatry; 2019 Sep; 59():67-72. PubMed ID: 31276904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Valproic Acid-Associated Hyperammonemia: A Systematic Review.
    Wong YJ, Fan J, Wan A, Mihic T, Gnyra M.
    J Clin Psychopharmacol; 2019 Sep; 43(3):283-294. PubMed ID: 37126830
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017 Sep; 117(6):106-110. PubMed ID: 28745680
    [Abstract] [Full Text] [Related]

  • 20. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H, Shishido T, Mukai T, Araki M, Naka H, Tokinobu H.
    Rinsho Shinkeigaku; 2019 May 28; 59(5):258-263. PubMed ID: 31061301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.